Trade ADCT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
ADC Therapeutics SA (ADCT) is trading at US$1.22, down 6.15% today as of Sep 9, 16:00 EDT. The company has a market capitalisation of US$127.23M. Over the past 52 weeks, ADCT has traded between US$0.78 and US$4.98. On Syfe you can trade ADCT with $0 commission and add it to your watchlist.
| Previous close | US$1.30 |
|---|---|
| Market cap | US$127.23M |
| 52-week range | US$0.78 – US$4.98 |
| Volume | 1.71M |
| Exchange | US |
Add to Watchlist
Set Price Alert
ADC Therapeutics SA
ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Year: 2020
ADC Therapeutics Completes Enrollment in LOTIS-7 Lymphoma Study
Jun 30, 1:16 PM · MT Newswires
Sector Update: Healthcare Stocks Rise Pre-Bell Wednesday
Jun 24, 1:22 PM · MT Newswires
ADC Therapeutics Cuts 17% of Workforce, Targets $10 Million in Annual Savings
Jun 24, 11:45 AM · MT Newswires
ADC Therapeutics Shares Fall After HC Wainwright Downgrade
Jun 8, 6:52 PM · MT Newswires
ADC Therapeutics SA (ADCT) stock is trading at US$1.22, -6.15% from the previous close of US$1.30.
The market cap for ADC Therapeutics SA (ADCT) stock is approximately US$127.23M.
The 52-week high for ADC Therapeutics SA (ADCT) stock is US$4.98.
The 52-week low for ADC Therapeutics SA (ADCT) stock is US$0.78.
ADC Therapeutics SA (ADCT) does not currently pay a dividend.
Stay on top of ADCT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
